Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat

The response of post-synaptic neurokinin receptors to SP were not changed by pirenzepine or N-methyl-scopolamine. Atropine led to a slight increase in the EC 50 of SP for its post-synaptic neurokinin (NK-A) receptor. In the presence of neostigmine no changes in the Emax and EC 50 values of SP for it...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropeptides (Edinburgh) 1988-05, Vol.11 (4), p.153-157
Hauptverfasser: Silva, W.I., Miranda, H.F., Wolstenholme, W.W., Cuevas, N., Ucros, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 157
container_issue 4
container_start_page 153
container_title Neuropeptides (Edinburgh)
container_volume 11
creator Silva, W.I.
Miranda, H.F.
Wolstenholme, W.W.
Cuevas, N.
Ucros, A.
description The response of post-synaptic neurokinin receptors to SP were not changed by pirenzepine or N-methyl-scopolamine. Atropine led to a slight increase in the EC 50 of SP for its post-synaptic neurokinin (NK-A) receptor. In the presence of neostigmine no changes in the Emax and EC 50 values of SP for its post- and pre-synaptic receptor site were observed. Only the muscarinic receptor site were observed. Only the muscarinic receptor antagonists, atropine and NMS, elicited statistically significant increases in the Emax of SP st its pre-synaptic receptor (NK-A). Addition of 7.4–740 nM SP resulted in a decrease in the EC 50 and Emax values of ACh for its post-synaptic muscarinic receptor (M1). Conversely, 740 nM SP produced an increase in the EC 50 and Emax values of ACh at its pre-synaptic muscarinic receptor (M2). Concentrations of 7.4 and 74 nM SP did not produce statistically significant changes in the Emax of ACh for its pre-synaptic M2 receptor.
doi_str_mv 10.1016/0143-4179(88)90068-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78427229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0143417988900686</els_id><sourcerecordid>14961521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-9fc703b2dee9588835d72500927c16540104ebac3bdcf4c871797d0cbcb171f73</originalsourceid><addsrcrecordid>eNqFkU1PxCAQhonR6PrxDzThYIweqkCh0IuJMX4lRj3omVCYRkxbVmhN_Pey7maPeiJhnncYnkHokJJzSmh1QSgvC05lfarUWU1IpYpqA82oKFnBpBKbaLZGdtBuSh-EEM6U2kbbjAslymqGzBNMMfTBTZ0ZQ_zGxo4-DAmHFqepSaMZLOAXHAY8vgPup2RN9IO3OIKFeY78ooval0nYQQsRhvVdNOM-2mpNl-Bgde6ht9ub1-v74vH57uH66rGwecCxqFsrSdkwB1ALpVQpnGSCkJpJSyvBCSUcGmPLxtmWWyXzr6QjtrENlbSV5R46Wfadx_A5QRp175OFrjMDhClpqTiTjNX_gpTXFRWMZpAvQRtDShFaPY--N_FbU6IXK9ALv3rhVyulf1egqxw7WvWfmh7cOrRynuvHq7rJMrs2ZsU-rTGZ3yelyNjlEoMs7ctD1Ml6yNtwPqsftQv-7zl-ADqKojQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14961521</pqid></control><display><type>article</type><title>Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Silva, W.I. ; Miranda, H.F. ; Wolstenholme, W.W. ; Cuevas, N. ; Ucros, A.</creator><creatorcontrib>Silva, W.I. ; Miranda, H.F. ; Wolstenholme, W.W. ; Cuevas, N. ; Ucros, A.</creatorcontrib><description>The response of post-synaptic neurokinin receptors to SP were not changed by pirenzepine or N-methyl-scopolamine. Atropine led to a slight increase in the EC 50 of SP for its post-synaptic neurokinin (NK-A) receptor. In the presence of neostigmine no changes in the Emax and EC 50 values of SP for its post- and pre-synaptic receptor site were observed. Only the muscarinic receptor site were observed. Only the muscarinic receptor antagonists, atropine and NMS, elicited statistically significant increases in the Emax of SP st its pre-synaptic receptor (NK-A). Addition of 7.4–740 nM SP resulted in a decrease in the EC 50 and Emax values of ACh for its post-synaptic muscarinic receptor (M1). Conversely, 740 nM SP produced an increase in the EC 50 and Emax values of ACh at its pre-synaptic muscarinic receptor (M2). Concentrations of 7.4 and 74 nM SP did not produce statistically significant changes in the Emax of ACh for its pre-synaptic M2 receptor.</description><identifier>ISSN: 0143-4179</identifier><identifier>EISSN: 1532-2785</identifier><identifier>DOI: 10.1016/0143-4179(88)90068-6</identifier><identifier>PMID: 2458536</identifier><identifier>CODEN: NRPPDD</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Atropine - pharmacology ; Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; In Vitro Techniques ; Male ; Muscle, Smooth - drug effects ; Muscle, Smooth - innervation ; N-Methylscopolamine ; Neostigmine - pharmacology ; Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ ; Pirenzepine - pharmacology ; Rats ; Rats, Inbred Strains ; Receptors, Muscarinic - drug effects ; Receptors, Neurokinin-1 ; Receptors, Neurotransmitter - drug effects ; Scopolamine Derivatives - pharmacology ; Substance P - antagonists &amp; inhibitors ; Substance P - pharmacology ; Vas Deferens - drug effects ; Vas Deferens - innervation ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuropeptides (Edinburgh), 1988-05, Vol.11 (4), p.153-157</ispartof><rights>1988</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-9fc703b2dee9588835d72500927c16540104ebac3bdcf4c871797d0cbcb171f73</citedby><cites>FETCH-LOGICAL-c417t-9fc703b2dee9588835d72500927c16540104ebac3bdcf4c871797d0cbcb171f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0143417988900686$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7149035$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2458536$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva, W.I.</creatorcontrib><creatorcontrib>Miranda, H.F.</creatorcontrib><creatorcontrib>Wolstenholme, W.W.</creatorcontrib><creatorcontrib>Cuevas, N.</creatorcontrib><creatorcontrib>Ucros, A.</creatorcontrib><title>Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat</title><title>Neuropeptides (Edinburgh)</title><addtitle>Neuropeptides</addtitle><description>The response of post-synaptic neurokinin receptors to SP were not changed by pirenzepine or N-methyl-scopolamine. Atropine led to a slight increase in the EC 50 of SP for its post-synaptic neurokinin (NK-A) receptor. In the presence of neostigmine no changes in the Emax and EC 50 values of SP for its post- and pre-synaptic receptor site were observed. Only the muscarinic receptor site were observed. Only the muscarinic receptor antagonists, atropine and NMS, elicited statistically significant increases in the Emax of SP st its pre-synaptic receptor (NK-A). Addition of 7.4–740 nM SP resulted in a decrease in the EC 50 and Emax values of ACh for its post-synaptic muscarinic receptor (M1). Conversely, 740 nM SP produced an increase in the EC 50 and Emax values of ACh at its pre-synaptic muscarinic receptor (M2). Concentrations of 7.4 and 74 nM SP did not produce statistically significant changes in the Emax of ACh for its pre-synaptic M2 receptor.</description><subject>Animals</subject><subject>Atropine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - innervation</subject><subject>N-Methylscopolamine</subject><subject>Neostigmine - pharmacology</subject><subject>Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ</subject><subject>Pirenzepine - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Receptors, Muscarinic - drug effects</subject><subject>Receptors, Neurokinin-1</subject><subject>Receptors, Neurotransmitter - drug effects</subject><subject>Scopolamine Derivatives - pharmacology</subject><subject>Substance P - antagonists &amp; inhibitors</subject><subject>Substance P - pharmacology</subject><subject>Vas Deferens - drug effects</subject><subject>Vas Deferens - innervation</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0143-4179</issn><issn>1532-2785</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1PxCAQhonR6PrxDzThYIweqkCh0IuJMX4lRj3omVCYRkxbVmhN_Pey7maPeiJhnncYnkHokJJzSmh1QSgvC05lfarUWU1IpYpqA82oKFnBpBKbaLZGdtBuSh-EEM6U2kbbjAslymqGzBNMMfTBTZ0ZQ_zGxo4-DAmHFqepSaMZLOAXHAY8vgPup2RN9IO3OIKFeY78ooval0nYQQsRhvVdNOM-2mpNl-Bgde6ht9ub1-v74vH57uH66rGwecCxqFsrSdkwB1ALpVQpnGSCkJpJSyvBCSUcGmPLxtmWWyXzr6QjtrENlbSV5R46Wfadx_A5QRp175OFrjMDhClpqTiTjNX_gpTXFRWMZpAvQRtDShFaPY--N_FbU6IXK9ALv3rhVyulf1egqxw7WvWfmh7cOrRynuvHq7rJMrs2ZsU-rTGZ3yelyNjlEoMs7ctD1Ml6yNtwPqsftQv-7zl-ADqKojQ</recordid><startdate>19880501</startdate><enddate>19880501</enddate><creator>Silva, W.I.</creator><creator>Miranda, H.F.</creator><creator>Wolstenholme, W.W.</creator><creator>Cuevas, N.</creator><creator>Ucros, A.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19880501</creationdate><title>Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat</title><author>Silva, W.I. ; Miranda, H.F. ; Wolstenholme, W.W. ; Cuevas, N. ; Ucros, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-9fc703b2dee9588835d72500927c16540104ebac3bdcf4c871797d0cbcb171f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Animals</topic><topic>Atropine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - innervation</topic><topic>N-Methylscopolamine</topic><topic>Neostigmine - pharmacology</topic><topic>Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ</topic><topic>Pirenzepine - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Receptors, Muscarinic - drug effects</topic><topic>Receptors, Neurokinin-1</topic><topic>Receptors, Neurotransmitter - drug effects</topic><topic>Scopolamine Derivatives - pharmacology</topic><topic>Substance P - antagonists &amp; inhibitors</topic><topic>Substance P - pharmacology</topic><topic>Vas Deferens - drug effects</topic><topic>Vas Deferens - innervation</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, W.I.</creatorcontrib><creatorcontrib>Miranda, H.F.</creatorcontrib><creatorcontrib>Wolstenholme, W.W.</creatorcontrib><creatorcontrib>Cuevas, N.</creatorcontrib><creatorcontrib>Ucros, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropeptides (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, W.I.</au><au>Miranda, H.F.</au><au>Wolstenholme, W.W.</au><au>Cuevas, N.</au><au>Ucros, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat</atitle><jtitle>Neuropeptides (Edinburgh)</jtitle><addtitle>Neuropeptides</addtitle><date>1988-05-01</date><risdate>1988</risdate><volume>11</volume><issue>4</issue><spage>153</spage><epage>157</epage><pages>153-157</pages><issn>0143-4179</issn><eissn>1532-2785</eissn><coden>NRPPDD</coden><abstract>The response of post-synaptic neurokinin receptors to SP were not changed by pirenzepine or N-methyl-scopolamine. Atropine led to a slight increase in the EC 50 of SP for its post-synaptic neurokinin (NK-A) receptor. In the presence of neostigmine no changes in the Emax and EC 50 values of SP for its post- and pre-synaptic receptor site were observed. Only the muscarinic receptor site were observed. Only the muscarinic receptor antagonists, atropine and NMS, elicited statistically significant increases in the Emax of SP st its pre-synaptic receptor (NK-A). Addition of 7.4–740 nM SP resulted in a decrease in the EC 50 and Emax values of ACh for its post-synaptic muscarinic receptor (M1). Conversely, 740 nM SP produced an increase in the EC 50 and Emax values of ACh at its pre-synaptic muscarinic receptor (M2). Concentrations of 7.4 and 74 nM SP did not produce statistically significant changes in the Emax of ACh for its pre-synaptic M2 receptor.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>2458536</pmid><doi>10.1016/0143-4179(88)90068-6</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-4179
ispartof Neuropeptides (Edinburgh), 1988-05, Vol.11 (4), p.153-157
issn 0143-4179
1532-2785
language eng
recordid cdi_proquest_miscellaneous_78427229
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Atropine - pharmacology
Biological and medical sciences
Fundamental and applied biological sciences. Psychology
In Vitro Techniques
Male
Muscle, Smooth - drug effects
Muscle, Smooth - innervation
N-Methylscopolamine
Neostigmine - pharmacology
Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ
Pirenzepine - pharmacology
Rats
Rats, Inbred Strains
Receptors, Muscarinic - drug effects
Receptors, Neurokinin-1
Receptors, Neurotransmitter - drug effects
Scopolamine Derivatives - pharmacology
Substance P - antagonists & inhibitors
Substance P - pharmacology
Vas Deferens - drug effects
Vas Deferens - innervation
Vertebrates: nervous system and sense organs
title Neuromodulatory actions of substance P on the muscarinic receptors of the vas deferens of the rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A02%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuromodulatory%20actions%20of%20substance%20P%20on%20the%20muscarinic%20receptors%20of%20the%20vas%20deferens%20of%20the%20rat&rft.jtitle=Neuropeptides%20(Edinburgh)&rft.au=Silva,%20W.I.&rft.date=1988-05-01&rft.volume=11&rft.issue=4&rft.spage=153&rft.epage=157&rft.pages=153-157&rft.issn=0143-4179&rft.eissn=1532-2785&rft.coden=NRPPDD&rft_id=info:doi/10.1016/0143-4179(88)90068-6&rft_dat=%3Cproquest_cross%3E14961521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14961521&rft_id=info:pmid/2458536&rft_els_id=0143417988900686&rfr_iscdi=true